PPD Inc. Common Stock
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.
PPD Overview
Sector |
Health Care |
Industry |
Biotechnology: Commercial Physical & Biological Resarch |
Previous Close |
$35.9900 |
Previous Close Volume |
1205776 |